Home / Health / Acne's New Hero? Science Backs Spironolactone
Acne's New Hero? Science Backs Spironolactone
3 Jul
Summary
- Spironolactone, an old diuretic, is now a proven acne treatment.
- Recent trials confirm its effectiveness, showing clearer skin.
- It targets hormonal acne by blocking androgen receptors.
Spironolactone, first approved as a diuretic in 1960, is now recognized for its efficacy in treating acne. Initially an off-label use based on anecdotal evidence from the 1980s, its mechanism involves blocking androgen receptors to reduce oil production.
The drug's effectiveness has been robustly demonstrated in recent clinical trials. The 2023 SAFA trial, involving 410 women across 10 UK centers, showed significantly clearer skin in those taking spironolactone compared to a placebo. A subsequent French trial compared it directly against doxycycline, with a Mayo Clinic review of 395 women indicating substantial improvement.
By 2024, the American Academy of Dermatology incorporated spironolactone into its official acne guidelines. It is particularly effective for hormonally patterned acne, addressing issues like adult onset, lower face flare-ups, and cyclical breakouts. Unlike isotretinoin, it does not typically require extensive monitoring or pregnancy precautions.
While spironolactone is a maintenance drug and not a cure, it offers a continuous solution for clear skin. Its appeal is often contrasted with older protocols of isotretinoin, though newer dosing strategies for isotretinoin have also reduced side effects. The choice between spironolactone and isotretinoin depends on acne severity and individual patient needs, ideally made in consultation with a dermatologist.
